Stefano Canosa

ORCID: 0000-0001-6402-6750 · 15 papers in corpus
2025
Life (Basel, Switzerland) ·doi:10.3390/life15020233

As we reach the conclusion of this Special Issue, Obstetrics and Gynecology Medicine: Go From Bench to Bedside, it is evident that the dynamic intersection between basic science and clinical practice continues to drive the evolution of care…

2023
Journal of clinical medicine ·doi:10.3390/jcm12124032

Background: The proportion of frozen embryo transfer cycles has consistently grown in recent decades. Some adverse obstetric outcomes after frozen embryo transfer could possibly be explained by different approaches in endometrial preparatio…

2022
International journal of molecular sciences ·doi:10.3390/ijms23041931

The cyclic regeneration of human endometrium is guaranteed by the proliferative capacity of endometrial mesenchymal stromal cells (E-MSCs). Due to this, the autologous infusion of E-MSCs has been proposed to support endometrial growth in a …

book-chapter 2022
·doi:10.1007/978-3-030-90111-0_8
article 2022
International journal of molecular sciences ·doi:10.3390/ijms23031775

Endometrial mesenchymal stromal cells (E-MSCs) extensively contribute to the establishment and progression of endometrial ectopic lesions through formation of the stromal vascular tissue, and support to its growth and vascularization. As E-…

2022
Journal of clinical medicine ·doi:10.3390/jcm11030859

(1) Background: Several researchers have investigated alternative markers related to ovarian responsiveness in order to better predict IVF outcomes, particularly in advanced reproductive-aged women. The follicular output rate (FORT), the fo…

article 2021
Journal of clinical medicine ·doi:10.3390/jcm10081757

Some studies have shown that ICSI obtains poorer results than conventional IVF in women with ovarian endometriosis, suggesting that oocytes could be sensitive to ICSI-induced mechanical damage. The aims of this study were to clarify (a) whe…

2020
International journal of molecular sciences ·doi:10.3390/ijms21093245

Novel anti-cancer treatments have improved the survival rates of female young patients, reopening pregnancy issues for female cancer survivors affected by the tumor treatment-related infertility. This condition occurs in approximately one t…

2020
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-020-01820-8

ObjectiveTo assess whether receiving information about twin pregnancy in the form of oral presentation given by a physician could affect the acceptance of single embryo transfer (SET) by couples undergoing IVF.Study designProspective interv…

2020
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-020-01806-6

To assess whether morphokinetic features at the cleavage stage together with specific gene expression in cumulus cells (CCs) may be used to predict whether human embryos are able to achieve the expanded blastocyst stage on day 5. Eighty-one…

2019
Journal of clinical medicine ·doi:10.3390/jcm8101694

This study compared the cumulative live birth rates following Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilization (cIVF) in women aged 40 years or more and unexplained infertility. A cohort of 685 women underg…

article 2017
Molecular human reproduction ·doi:10.1093/molehr/gax006

Study Question: Can endometrial mesenchymal stromal cells (E-MSCs) differentiate into endothelial cells in an in vitro co-culture system with human umbilical vein endothelial cells (HUVECs)? Summary Answer: E-MSCs can acquire endothelial ma…

preprint 2016
·doi:10.26226/morressier.573c1512d462b80296c986a5
2016
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-016-0675-7

PurposeThe aims of this study were to assess the outcome of in vitro fertilization (IVF) in women with very low circulating anti-müllerian hormone (AMH) and to investigate factors affecting their probability of pregnancy.MethodsThe outcome …

2015
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-015-0080-6

BackgroundThe association of recombinant FSH (rFSH) plus recombinant LH (rLH) is currently used for Controlled Ovarian Stimulation (COS) in human IVF, but its efficacy has, to date, not yet been compared to that of human Menopausal Gonadotr…